Sign In
Buy PODD
$143.30
+0.87 (+0.611%)
At Close: Jun 03, 2026
Insulet (PODD) stock up 14% on positive earnings and growth forecast
12:03pm, Friday, 03'rd Nov 2023
Shares of medical device company Insulet Corporation (NASDAQ: PODD) witnessed a remarkable surge, jumping by 14% on Friday in response to the company's recent earnings report. The substantial increase
Insulet Stock Rallies on Revenue Boost. It's a 'Misunderstood Growth Name.
11:04am, Friday, 03'rd Nov 2023
The automated insulin technology developer posts third-quarter revenue of $432.7 million, compared with $340.8 million a year earlier.
Insulet shares rebound after results top estimates
08:33am, Friday, 03'rd Nov 2023
Insulet Corp. shares PODD, +1.98% climbed 10% premarket on Friday after the insulin pump maker late Thursday reported third-quarter results that beat expectations and aimed to dispel some investor fea
Insulet Corporation (PODD) Q3 2023 Earnings Call Transcript
10:10pm, Thursday, 02'nd Nov 2023
Insulet Corporation (NASDAQ:PODD ) Q3 2023 Earnings Conference Call November 2, 2023 4:30 PM ET Company Participants Deborah Gordon - Vice President, Investor Relations Jim Hollingshead - President &
Insulet (PODD) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
06:47pm, Thursday, 02'nd Nov 2023
While the top- and bottom-line numbers for Insulet (PODD) give a sense of how the business performed in the quarter ended September 2023, it could be worth looking at how some of its key metrics compa
Insulet Corporation: Still No Bargain
05:14pm, Monday, 30'th Oct 2023
Today, we take a look at Insulet Corporation, a mid-cap medical device concern. The company is focused on developing and marketing insulin delivery systems for people with diabetes and has a 'best of
Is Insulet (PODD) a Solid Growth Stock? 3 Reasons to Think "Yes"
02:19pm, Wednesday, 25'th Oct 2023
Insulet (PODD) is well positioned to outperform the market, as it exhibits above-average growth in financials.
EYE vs. PODD: Which Stock Is the Better Value Option?
12:47pm, Tuesday, 24'th Oct 2023
Investors with an interest in Medical - Products stocks have likely encountered both National Vision (EYE) and Insulet (PODD). But which of these two stocks is more attractive to value investors?
4 Medical Product Stocks Set to Outpace Q3 Earnings Estimates
08:16am, Thursday, 19'th Oct 2023
Medical Product companies' results are likely to reflect base business recovery on a year-over-year basis. Let's see how EW, PODD, DXCM and IQV are poised ahead of their earnings release.
MedTech Earnings in the Age of Ozempic May Not Be That Bad
02:01pm, Tuesday, 17'th Oct 2023
September-quarter earnings among medical-device makers may prove better than expected in the age of weight-loss drugs.
Down -20.51% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a Turnaround
11:19am, Tuesday, 17'th Oct 2023
The heavy selling pressure might have exhausted for Insulet (PODD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in
Here's Why You Should Invest in Insulet (PODD) Stock for Now
12:02pm, Monday, 16'th Oct 2023
Investors are optimistic about Insulet (PODD) on continued expansion in Omnipod's market access.
Down -21.98% in 4 Weeks, Here's Why Insulet (PODD) Looks Ripe for a Turnaround
11:18am, Monday, 16'th Oct 2023
Insulet (PODD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising e
Why Insulet (PODD) is a Top Growth Stock for the Long-Term
11:17am, Friday, 13'th Oct 2023
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Shares of Insulet Dropped This Week
05:40pm, Thursday, 12'th Oct 2023
Insulet makes a tubeless insulin pump. The company is coming off a strong second quarter.
